Skin biopsy processing for rapid molecular diagnosis and histopathologic interpretation: application to Kaposi sarcoma in East Africa
- PMID: 40528209
- PMCID: PMC12175338
- DOI: 10.1186/s13027-025-00671-1
Skin biopsy processing for rapid molecular diagnosis and histopathologic interpretation: application to Kaposi sarcoma in East Africa
Abstract
Background: Kaposi sarcoma (KS) is a cancer of viral origin (Kaposi sarcoma-associated herpesvirus; KSHV) for which the detection of KSHV DNA is an attractive target for a rapid, automatable diagnostic test. We previously demonstrated favorable diagnostic accuracy using loop-mediated isothermal amplification (LAMP) to quantitate KSHV DNA in lesional skin biopsies, though extracting DNA from the punch biopsies was the time-limiting step. Herein, we describe the development of a biopsy processing tool called Slicer to enable rapid nucleic acid testing in addition to traditional histopathological interpretation.
Methods: Slicer divides skin punch biopsies into two ½-cylinders and a thin, cross-sectional slice. The thin slice enables a previously demonstrated, equipment-free alkaline extraction termed ColdSHOT while the remaining ½-cylinders are available for histopathological diagnosis and additional molecular testing as needed. Slicer prototypes were used on skin punch biopsies collected from patients in Uganda who were referred for clinical suspicion of KS.
Results: For 27 patient samples, the combination of Slicer and ColdSHOT sample processing with LAMP testing resulted in qualitative KSHV DNA detection that was fully concordant with US-based histopathological diagnoses. Additional analysis demonstrated compatibility of Slicer and ColdSHOT with qPCR for KSHV DNA quantitation.
Conclusions: These results warrant further investigation using a larger set of skin biopsies and indicate that the Slicer and ColdSHOT could enable accurate KS diagnosis within a few hours of biopsy collection with minimal equipment.
Keywords: Kaposi sarcoma; Nucleic acid testing; Point-of-care testing; Skin sample processing.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Ethics approval and consent to participate: IRB approval was provided by Cornell University under IRB 0006836. Consent for publication: Not applicable. Competing interests: The authors declare no competing interests.
Figures





Similar articles
-
Genome evolution of Kaposi sarcoma-associated herpesvirus (KSHV).J Virol. 2025 May 20;99(5):e0195024. doi: 10.1128/jvi.01950-24. Epub 2025 Apr 16. J Virol. 2025. PMID: 40237497 Free PMC article.
-
Molecular feature-based classification of retroperitoneal liposarcoma: a prospective cohort study.Elife. 2025 May 23;14:RP100887. doi: 10.7554/eLife.100887. Elife. 2025. PMID: 40407808 Free PMC article.
-
T-cells specific for KSHV and HIV migrate to Kaposi sarcoma tumors and persist over time.bioRxiv [Preprint]. 2025 Feb 15:2024.02.06.579223. doi: 10.1101/2024.02.06.579223. bioRxiv. 2025. PMID: 38370623 Free PMC article. Preprint.
-
Assessing the comparative effects of interventions in COPD: a tutorial on network meta-analysis for clinicians.Respir Res. 2024 Dec 21;25(1):438. doi: 10.1186/s12931-024-03056-x. Respir Res. 2024. PMID: 39709425 Free PMC article. Review.
-
Defining disease severity in atopic dermatitis and psoriasis for the application to biomarker research: an interdisciplinary perspective.Br J Dermatol. 2024 Jun 20;191(1):14-23. doi: 10.1093/bjd/ljae080. Br J Dermatol. 2024. PMID: 38419411 Free PMC article. Review.
References
-
- Chang Y, et al. Identification of Herpesvirus-Like DNA sequences in AIDS-Associated kaposi’s sarcoma. Science. 1994;266(5192):1865–9. - PubMed
-
- Nuovo M, Nuovo G. Utility of HHV8 RNA detection for differentiating kaposi’s sarcoma from its mimics. J Cutan Pathol. 2001;28(5):248–55. - PubMed
-
- Ferlay J, et al. Cancer statistics for the year 2020: an overview. Int J Cancer. 2021;149(4):778–89. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources